At a glance
- HMG, or human menopausal gonadotropin, is a biologic preparation with FSH and LH activity, historically purified from urine. It is a mixture of gonadotropin activities—not one defined peptide sequence.
- Regulated menotropin drug products are approved for specific fertility indications. This research vial is not one of those products, and mass in milligrams cannot establish international units of FSH/LH bioactivity, purity, sterility, or clinical equivalence.
- Quantify FSH and LH biological activity separately; total protein or vial mass is not a functional potency measure.
- Use receptor-specific cellular assays when the ratio of the two gonadotropin activities is the research question.
What HMG is—and what the name does not establish
HMG, or human menopausal gonadotropin, is a biologic preparation with FSH and LH activity, historically purified from urine. It is a mixture of gonadotropin activities—not one defined peptide sequence.
FSH activity supports follicular or Sertoli-cell pathways, while LH activity supports steroidogenic gonadal signalling. In plain language, HMG supplies two downstream pituitary hormone activities in one preparation rather than prompting the pituitary to release them.
Questions to settle before interpreting a result
A useful HMG study begins with material identity, a defined model, a relevant comparator, and an endpoint chosen before the result is known. Broad catalogue language cannot replace those controls.
- Quantify FSH and LH biological activity separately; total protein or vial mass is not a functional potency measure.
- Use receptor-specific cellular assays when the ratio of the two gonadotropin activities is the research question.
- Compare HMG with HCG or gonadorelin only after mapping where each acts along the reproductive axis.
How to read the HMG evidence
These evidence snapshots summarize the most important distinctions in the published record. They do not combine unlike models or turn an experimental signal into a human-use claim.
Human evidence · established products
- Design
- Menotropins are clinically validated in fertility care
- Finding
- Approved preparations have product-specific bioactivity, purification, dosing, and monitoring evidence. That class history does not validate an independently labelled research vial.
- Read with care
- This is an interpretation boundary, not a claim that a specific outcome has been established in people.
Potency question
- Design
- International units matter more than simple mass
- Finding
- HMG is defined by gonadotropin activity. Two preparations with the same gross mass can produce different FSH/LH responses and impurity profiles.
- Read with care
- This is an interpretation boundary, not a claim that a specific outcome has been established in people.
Axis comparison
- Design
- HMG, HCG, and GnRH act at different levels
- Finding
- HMG supplies FSH/LH activity, HCG activates LH/CG receptors, and gonadorelin prompts pituitary release. Grouping them together without that map hides the actual research choice.
- Read with care
- This is an interpretation boundary, not a claim that a specific outcome has been established in people.
What the evidence does not establish
Regulated menotropin drug products are approved for specific fertility indications. This research vial is not one of those products, and mass in milligrams cannot establish international units of FSH/LH bioactivity, purity, sterility, or clinical equivalence.
Mechanism, cell, animal, observational, and controlled human evidence answer different questions. A positive result at one level cannot be silently promoted to another, and evidence for a sponsor’s defined product does not establish equivalence for an independently sourced research material.
Keep the publication and the vial separate
A published paper identifies its own sequence or chemical identity, formulation, manufacturing context, analytical controls, exposure, and test system. Matching a familiar name on a label is not enough to show that a catalogue vial is the same study material.
For practical research planning, verify the lot-specific identity and documentation, then write the model, comparator, endpoint, and stopping criteria before testing. This guide does not provide preparation, dosing, injection, or human-use instructions.
Sources
Links lead to the paper, official registry, regulator page, or product label used for this guide. Registry records describe protocols and status; they are not treated as positive results.
- Menopur (menotropins) official prescribing informationDailyMed · U.S. National Library of Medicine · Current label
Official label for a regulated menotropin product with defined international-unit activity and manufacturing controls. It does not establish equivalence for a generic HMG vial.
- Think twice before injecting peptides bought online: unauthorized products can seriously harm youHealth Canada · 2026
Official Canadian advisory explaining that a research-use label does not establish authorization, safety, efficacy, or product quality for human use.
Vote for HMG
This compound is not currently stocked. Add it to your five-choice catalogue ballot.